– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR and mPFS 9.1 months in histology selective cohort of multiple late line, difficult to treat cancers provide further evidence of strong activity – – $225 million in gross proceeds from October 2025 financing extends cash runway into 2028 – BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tango Th ...

VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-driven drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, announces the expansion of its drone manufacturing operations in Sharjah, UAE, nearby Dubai, enabling space to scale production, R&D work, and Drone as a Service operations. This expansion is a key part of ZenaTech’s strategy to me ...

Treasury Secretary is joining us now. Uh Scott Besson, we we worked on that that segue. Uh Mr.. Treasury Secretary, I hope you liked it. How are you. Good good to see you.>> Good morning, Joe. Good to see you. >> You uh let's talk tariffs and and and uh since it's front and center for everyone with with this beginning now at at Scotas, you have said you're going and um you want to be in the front row.I think you're I think your chances are good if you say that's where you'd like to sit. Uh, look, Joe, I I t ...

Zoetis slashes its full-year outlook. ...

Core Insights - The London Company reported a 6.3% return for its Large Cap Strategy in Q3 2025, underperforming the Russell 1000 Index which gained 8.0% [1] - The US economy maintained momentum despite mixed economic data, driven by a Fed rate cut, strong corporate earnings, and enthusiasm for AI [1] Company Overview: Equitable Holdings, Inc. (NYSE:EQH) - Equitable Holdings is a diversified financial services company focused on retirement and wealth management, managing over $1 trillion in client assets [3] - The stock experienced a one-month return of -4.28% but gained 9.67% over the past 52 weeks, closing at $48.79 with a market cap of $14.614 billion on November 3, 2025 [2] - The company operates with an asset-light model, generating strong free cash flow used for share repurchases and dividend growth, with an annual share count decline of about 8% and a dividend growth rate of 7% [3] Recent Developments - A recent reinsurance transaction with Venerable released nearly $2 billion in excess capital, reducing risk and validating reserves for Equitable Holdings [3] - The company is shifting towards higher-quality, fee-based retirement and asset management businesses, which is expected to enhance its market valuation [3] Market Position - Equitable Holdings is not among the top 30 most popular stocks among hedge funds, with 42 hedge fund portfolios holding the stock at the end of Q2 2025, down from 49 in the previous quarter [4] - While the company shows potential, certain AI stocks are viewed as having greater upside potential and lower downside risk [4]

The Trade Desk ( TTD ) has experienced a massive sell-off after the Q2 earnings release mostly because of a cautious Q3 guidance from the management. I think that TTD is highly likely to outperform in realityI am a highly experienced Chief Financial Officer (CFO) with a strong background in the oilfield and real estate industries. With over a decade of experience in finance, I have led numerous complex due diligence efforts and M&A transactions, both domestically and internationally.In recent years, I have ...

Core Insights - Microsoft is set to ship Nvidia's most advanced AI chips to the United Arab Emirates, following approval from the U.S. Commerce Department [1] Company Summary - Microsoft is actively engaging in the AI chip market by facilitating the shipment of advanced technology [1] - The deal signifies a strategic partnership between Microsoft and Nvidia, enhancing their presence in the Middle East [1] Industry Summary - The approval from the U.S. Commerce Department highlights the regulatory environment surrounding AI technology exports [1] - This move may indicate a growing demand for advanced AI solutions in the UAE, reflecting broader trends in the global AI market [1]

Welcome to the Green Stock news brief for Tuesday, November 4th. Here are today's top headlines. Eve Air Mobility has signed a framework agreement with Bahrain's Ministry of Transportation and Telecommunications to advance sustainable EV toll air mobility across the Middle East.The partnership will develop regulations, infrastructure, and training for zero emission operations with commercial flights planned for 2028 and international routes by 2029. Intuitive Machines has announced an $800 million agreement ...

This is a comparison of how Tesla (TSLA) stock compares to its competitors in terms of size, valuation, growth, and margin. GRUENHEIDE, GERMANY - JULY 17: A stop sign stands near the Tesla logo at the Tesla factory on July 17, 2023 near Gruenheide, Germany. Tesla will reportedly present its plans tomorrow to expand production at the factory, from thee current level of approximately 250,000 cars per year to one million. The plan calls for the construction of a new assembly hall that will be the size of 60 so ...

Core Insights - The London Company reported a 6.3% return (6.2% net) for its Large Cap Strategy in Q3 2025, underperforming the Russell 1000 Index which gained 8.0% during the same period [1] - The overall economic momentum remained strong despite mixed economic data in Q3 2025, driven by a Fed rate cut, solid corporate earnings, and enthusiasm around AI [1] Company-Specific Insights - Bruker Corporation (NASDAQ:BRKR) was highlighted in the investor letter, with a one-month return of 6.17% but a significant 34.78% decline over the past 52 weeks, closing at $38.71 per share with a market capitalization of $5.873 billion on November 3, 2025 [2] - The London Company decided to exit its position in Bruker Corporation due to significant underperformance since purchase in 2024, citing weak pharma spending, potential cuts to NIH and academic funding, and tariff concerns as headwinds [3] - Bruker Corporation is not among the 30 most popular stocks among hedge funds, with 42 hedge fund portfolios holding the stock at the end of Q2 2025, an increase from 40 in the previous quarter [4]